- Rating
- 1
- Confidence
- 4
- Informativeness
- 1
- Presentation
- 1
- Soundness
- 1
Read review
Paper summary
This paper proposes TACC, a task-aware color constancy framework for smartphone creatinine-strip kidney-disease detection: TACC-GAN maps heterogeneous-lighting images to a canonical white-light domain via a tripartite-mask conditional GAN, and NeurSPR uses a differentiable histogram with soft MoE regression to backpropagate diagnostic losses. All experiments rest on 2,016 images of 504 laboratory-prepared strips under 4 scripted lighting conditions, reporting the best deployable classification F1 per condition. Overall, the workload is minimal, the figures are poor, and the exposition is unclear—far below the ICLR standard; I recommend strong rejection.
Critical strengths
- The task-aware motivation has practical value. Aligning the optimization objective of color correction with downstream diagnostic accuracy rather than perceptual quality, applied to low-cost kidney monitoring, is a meaningful entry point.
Critical weaknesses
-
The workload is minimal and far short of a top-tier conference paper: everything rests on a single small dataset of 504 laboratory strips, and the claimed demographic stratification is merely synthetic metadata rather than real patients. The method directly assembles existing components, and NeurSPR's F1 gain over the strongest classical baseline is only 0.01—closer to a workshop paper.
-
Poor figures and sloppy presentation: the key results figure, Figure 4, labels 8-bit "Pixel Value 0–240" axes as Lab channels, directly contradicting the text, and its subplot scales are incomparable. Table 2 contains the "0.0.8515" error, and the KDE-overlap metric announced in Section 4.3 is never reported numerically anywhere.
-
Confusing exposition with missing key details: the color space, bin count K, and bandwidth σ of the differentiable histogram are unspecified, and the loss weights in Eq. (4) contradict Section 4.4. The generator/discriminator architectures and mask acquisition are also undescribed, hindering understanding and reproduction.
Questions for authors
-
What is the concrete dataset-expansion plan—what target scale, and will it include multiple phone models and self-captured images from real patients? Will there be validation against laboratory serum creatinine assays rather than eGFR labels derived from synthetic metadata?
-
Will you fix the axis/color-space contradiction in Figure 4 and errors such as "0.0.8515" in Table 2? Please report the KDE-overlap values (by method × lighting condition) rather than passing over them with a single qualitative figure.
-
Please clarify the differentiable histogram implementation (color space, K, µ_k, σ, t_k) and resolve the loss-weight contradiction between Eq. (4) and Section 4.4. The generator/discriminator architectures, image resolution, and mask acquisition also need to be supplied.